Menu
×
West Ashley Library
9 a.m. - 7 p.m.
Phone: (843) 766-6635
Folly Beach Library
Closed
Phone: (843) 588-2001
Edgar Allan Poe/Sullivan's Island Library
Closed for renovations
Phone: (843) 883-3914
Wando Mount Pleasant Library
9 a.m. - 8 p.m.
Phone: (843) 805-6888
Village Library
9 a.m. - 1 p.m.
Phone: (843) 884-9741
St. Paul's/Hollywood Library
9 a.m. - 8 p.m.
Phone: (843) 889-3300
Otranto Road Library
9 a.m. - 8 p.m.
Phone: (843) 572-4094
Mt. Pleasant Library
9 a.m. - 8 p.m.
Phone: (843) 849-6161
McClellanville Library
9 a.m. - 6 p.m.
Phone: (843) 887-3699
Keith Summey North Charleston Library
9 a.m. - 8 p.m.
Phone: (843) 744-2489
John's Island Library
9 a.m. - 8 p.m.
Phone: (843) 559-1945
Hurd/St. Andrews Library
9 a.m. - 8 p.m.
Phone: (843) 766-2546
Miss Jane's Building (Edisto Library Temporary Location)
2 p.m. – 6 p.m.
Phone: (843) 869-2355
Dorchester Road Library
9 a.m. - 8 p.m.
Phone: (843) 552-6466
John L. Dart Library
9 a.m. - 7 p.m.
Phone: (843) 722-7550
Baxter-Patrick James Island
9 a.m. - 8 p.m.
Phone: (843) 795-6679
Main Library
9 a.m. - 8 p.m.
Phone: (843) 805-6930
Bees Ferry West Ashley Library
9 a.m. - 8 p.m.
Phone: (843) 805-6892
Mobile Library
9 a.m. - 5 p.m.
Phone: (843) 805-6909
Today's Hours
West Ashley Library
9 a.m. - 7 p.m.
Phone: (843) 766-6635
Folly Beach Library
Closed
Phone: (843) 588-2001
Edgar Allan Poe/Sullivan's Island Library
Closed for renovations
Phone: (843) 883-3914
Wando Mount Pleasant Library
9 a.m. - 8 p.m.
Phone: (843) 805-6888
Village Library
9 a.m. - 1 p.m.
Phone: (843) 884-9741
St. Paul's/Hollywood Library
9 a.m. - 8 p.m.
Phone: (843) 889-3300
Otranto Road Library
9 a.m. - 8 p.m.
Phone: (843) 572-4094
Mt. Pleasant Library
9 a.m. - 8 p.m.
Phone: (843) 849-6161
McClellanville Library
9 a.m. - 6 p.m.
Phone: (843) 887-3699
Keith Summey North Charleston Library
9 a.m. - 8 p.m.
Phone: (843) 744-2489
John's Island Library
9 a.m. - 8 p.m.
Phone: (843) 559-1945
Hurd/St. Andrews Library
9 a.m. - 8 p.m.
Phone: (843) 766-2546
Miss Jane's Building (Edisto Library Temporary Location)
2 p.m. – 6 p.m.
Phone: (843) 869-2355
Dorchester Road Library
9 a.m. - 8 p.m.
Phone: (843) 552-6466
John L. Dart Library
9 a.m. - 7 p.m.
Phone: (843) 722-7550
Baxter-Patrick James Island
9 a.m. - 8 p.m.
Phone: (843) 795-6679
Main Library
9 a.m. - 8 p.m.
Phone: (843) 805-6930
Bees Ferry West Ashley Library
9 a.m. - 8 p.m.
Phone: (843) 805-6892
Mobile Library
9 a.m. - 5 p.m.
Phone: (843) 805-6909
Patron Login
menu
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Defining and achieving treatment success in patients with type 2 diabetes mellitus.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
- Author(s): Stolar MW;Stolar MW
- Source:
Mayo Clinic proceedings [Mayo Clin Proc] 2010 Dec; Vol. 85 (12 Suppl), pp. S50-9. Date of Electronic Publication: 2010 Nov 24.- Publication Type:
Journal Article; Review- Language:
English - Source:
- Additional Information
- Source: Publisher: [Oxford, England] Country of Publication: England NLM ID: 0405543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-5546 (Electronic) Linking ISSN: 00256196 NLM ISO Abbreviation: Mayo Clin Proc Subsets: MEDLINE
- Publication Information: Publication: Jan. 2012- : [Oxford, England] : Elsevier
Original Publication: Rochester, MN : Mayo Foundation for Medical Education and Research - Subject Terms: Blood Glucose/*drug effects ; Diabetes Mellitus, Type 2/*drug therapy ; Dipeptidyl-Peptidase IV Inhibitors/*administration & dosage ; Glucagon-Like Peptide 1/*antagonists & inhibitors ; Hypoglycemic Agents/*administration & dosage ; Incretins/*administration & dosage; Blood Glucose/analysis ; Diabetes Complications/prevention & control ; Diabetes Mellitus, Type 2/diagnosis ; Dose-Response Relationship, Drug ; Female ; Glucagon-Like Peptide 1/analysis ; Humans ; Male ; Risk Assessment ; Safety Management ; Severity of Illness Index ; Total Quality Management ; Treatment Outcome ; United States
- Abstract: Traditionally, successful treatment of patients with type 2 diabetes mellitus (DM) has been defined strictly by achievement of targeted glycemic control, primarily using a stepped-care approach that begins with changes in lifestyle combined with oral therapy that is slowly intensified as disease progression advances and β-cell function declines. However, stepped care is often adjusted without regard to the mechanism of hyperglycemia or without long-term objectives. A more comprehensive definition of treatment success in patients with type 2 DM should include slowing or stopping disease progression and optimizing the reduction of all risk factors associated with microvascular and macrovascular disease complications. To achieve these broader goals, it is important to diagnose diabetes earlier in the disease course and to consider use of more aggressive combination therapy much earlier with agents that have the potential to slow or halt the progressive β-cell dysfunction and loss characteristic of type 2 DM. A new paradigm for managing patients with type 2 DM should address the concomitant risk factors and morbidities of obesity, hypertension, and dyslipidemia with equal or occasionally even greater aggressiveness than for hyperglycemia. The use of antidiabetes agents that may favorably address cardiovascular risk factors should be considered more strongly in treatment algorithms, although no pharmacological therapy is likely to be ultimately successful without concomitant synergistic lifestyle changes. Newer incretin-based therapies, such as glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase 4 inhibitors, which appear to have a favorable cardiovascular safety profile as well as the mechanistic possibility for a favorable cardiovascular risk impact, are suitable for earlier inclusion as part of combination regimens aimed at achieving comprehensive treatment success in patients with type 2 DM.
- References: Diabetes Care. 2010 May;33(5):951-7. (PMID: 20107105)
Am J Med. 2010 Apr;123(4):374.e 9 -18. (PMID: 20362759)
Am J Cardiol. 2007 Sep 1;100(5):824-9. (PMID: 17719327)
Lancet. 1998 Sep 12;352(9131):837-53. (PMID: 9742976)
Lancet. 2009 Nov 14;374(9702):1677-86. (PMID: 19878986)
Circulation. 2010 Feb 23;121(7):e46-e215. (PMID: 20019324)
Am J Kidney Dis. 2004 Nov;44(5):792-8. (PMID: 15492944)
Diabetes. 2007 Jun;56(6):1718-26. (PMID: 17369522)
N Engl J Med. 2009 Jan 8;360(2):129-39. (PMID: 19092145)
Diabetes Care. 2002 Jul;25(7):1129-34. (PMID: 12087009)
Diabetes. 2006 Feb;55(2):517-22. (PMID: 16443789)
Am J Manag Care. 2004 Dec;10(12):926-32. (PMID: 15617368)
J Card Fail. 2006 Dec;12(9):694-9. (PMID: 17174230)
Am Heart J. 2008 Apr;155(4):712-7. (PMID: 18371481)
N Engl J Med. 2005 Dec 22;353(25):2643-53. (PMID: 16371630)
J Manag Care Pharm. 2008 Jun;14(5 Suppl B):s2-19. (PMID: 18597582)
Diabetes Care. 2009 Jan;32(1):193-203. (PMID: 18945920)
Diabetes. 1995 Aug;44(8):863-70. (PMID: 7621989)
Endocr Rev. 2007 Apr;28(2):187-218. (PMID: 17353295)
N Engl J Med. 2006 Dec 7;355(23):2427-43. (PMID: 17145742)
Circulation. 2009 Jan 20;119(2):351-7. (PMID: 19095622)
BMJ. 1998 Mar 14;316(7134):823-8. (PMID: 9549452)
Lancet. 2006 Sep 23;368(9541):1096-105. (PMID: 16997664)
Ann Intern Med. 2009 Sep 15;151(6):394-403. (PMID: 19620144)
Isr Med Assoc J. 2003 Nov;5(11):801-6. (PMID: 14650106)
N Engl J Med. 2003 Jan 30;348(5):383-93. (PMID: 12556541)
Diabetes Care. 1990 Jun;13(6):610-30. (PMID: 2192847)
Clin Ther. 2003;25 Suppl B:B32-46. (PMID: 14553865)
Am J Clin Nutr. 2008 Jan;87(1):217S-222S. (PMID: 18175761)
Diabetes Care. 2006 Sep;29(9):2114-6. (PMID: 16936162)
Curr Med Res Opin. 2008 Jan;24(1):275-86. (PMID: 18053320)
JAMA. 2004 Jan 21;291(3):335-42. (PMID: 14734596)
Diabetes Obes Metab. 2008 Dec;10(12):1221-38. (PMID: 18505403)
N Engl J Med. 2008 Jun 12;358(24):2545-59. (PMID: 18539917)
Curr Atheroscler Rep. 2009 Mar;11(2):93-9. (PMID: 19228481)
Ann Fam Med. 2006 Sep-Oct;4(5):427-32. (PMID: 17003143)
Am J Physiol Endocrinol Metab. 2004 Dec;287(6):E1209-15. (PMID: 15353407)
Diabetes Obes Metab. 2004 Sep;6(5):319-31. (PMID: 15287924)
Am J Med. 2009 May;122(5):443-53. (PMID: 19375554)
Lancet. 2006 Nov 11;368(9548):1696-705. (PMID: 17098089)
Ann Epidemiol. 2008 Mar;18(3):222-9. (PMID: 18201902)
Diabetes Obes Metab. 2004 Jul;6(4):280-5. (PMID: 15171752)
Diabetes Metab Res Rev. 2007 Oct;23(7):518-27. (PMID: 17883249)
Diabetes Care. 2000 Aug;23(8):1103-7. (PMID: 10937505)
Int J Clin Pract. 2007 May;61(5):737-47. (PMID: 17493087)
Circulation. 2004 Mar 2;109(8):962-5. (PMID: 14981009)
Diabetes. 2006 Apr;55(4):1114-20. (PMID: 16567536)
Diabetes Care. 2006 Jan;29(1):154-7. (PMID: 16373917)
Diabetes. 2009 Apr;58(4):773-95. (PMID: 19336687)
Lancet. 2009 May 23;373(9677):1765-72. (PMID: 19465231)
Circulation. 2003 Feb 11;107(5):753-6. (PMID: 12578880)
Endocr Pract. 2007 May-Jun;13 Suppl 1:1-68. (PMID: 17613449)
Lancet. 2009 Jun 27;373(9682):2215-21. (PMID: 19515410)
Obesity (Silver Spring). 2010 May;18(5):926-31. (PMID: 19910937)
BMJ. 2009 Dec 03;339:b4731. (PMID: 19959591)
Diabetes Care. 2007 Mar;30(3):753-9. (PMID: 17327355)
Diabete Metab. 1977 Sep;3(3):173-82. (PMID: 913749)
Am Fam Physician. 1999 May 15;59(10):2835-44, 2849-50. (PMID: 10348076)
Scand J Prim Health Care. 2006 Sep;24(3):181-5. (PMID: 16923628)
Diabetes Care. 2008 Mar;31(3):464-9. (PMID: 18039804)
Am J Epidemiol. 1990 Apr;131(4):633-43. (PMID: 2316495)
Diabetes. 2002 Feb;51 Suppl 1:S240-4. (PMID: 11815486)
Int J Clin Pract Suppl. 2007 Jun;(153):10-9. (PMID: 17594389)
BMJ. 2000 Aug 12;321(7258):405-12. (PMID: 10938048)
Diabetes Care. 2010 Jan;33 Suppl 1:S11-61. (PMID: 20042772)
Diabetes. 2007 Apr;56(4):1153-9. (PMID: 17395752)
N Engl J Med. 2008 Feb 7;358(6):580-91. (PMID: 18256393)
Diabetes Res Clin Pract. 2001 May;52(2):145-52. (PMID: 11311969)
N Engl J Med. 2008 Oct 9;359(15):1577-89. (PMID: 18784090)
Lancet. 2004 Aug 21-27;364(9435):685-96. (PMID: 15325833)
N Engl J Med. 2008 Jun 12;358(24):2560-72. (PMID: 18539916)
Diabetes Care. 2003 Nov;26(11):2999-3005. (PMID: 14578230)
Diabetes. 2009 Nov;58(11):2642-8. (PMID: 19651816)
Am J Med. 2009 Jun;122(6 Suppl):S37-50. (PMID: 19464427)
N Engl J Med. 2008 Oct 9;359(15):1618-20. (PMID: 18843126)
Endocr Pract. 2009 Sep-Oct;15(6):540-59. (PMID: 19858063) - Accession Number: 0 (Blood Glucose)
0 (Dipeptidyl-Peptidase IV Inhibitors)
0 (Hypoglycemic Agents)
0 (Incretins)
89750-14-1 (Glucagon-Like Peptide 1) - Publication Date: Date Created: 20101126 Date Completed: 20101220 Latest Revision: 20211020
- Publication Date: 20231215
- Accession Number: PMC2996162
- Accession Number: 10.4065/mcp.2010.0471
- Accession Number: 21106864
- Source:
Contact CCPL
Copyright 2022 Charleston County Public Library Powered By EBSCO Stacks 3.3.0 [350.3] | Staff Login
No Comments.